Key result
The HCM-causing CSRP3 mutation C58G in a knock-in mouse model caused robust cardiomyopathy with left ventricular dysfunction and an 80% depletion of MLP protein due to proteasome action.
The CSRP3 C58G mutation causes hypertrophic cardiomyopathy through proteasome-mediated depletion of Muscle LIM Protein and a proteotoxic response.
Proteasome targeting merits investigation in CSRP3 cardiomyopathy; leaves open human translation and therapeutic testing.
Cysteine and glycine rich protein 3 (CSRP3) encodes Muscle LIM Protein (MLP), a well-established disease gene for Hypertrophic Cardiomyopathy (HCM). MLP, in contrast to the proteins encoded by the other recognised HCM disease genes, is non-sarcomeric, and has important signalling functions in cardiomyocytes. To gain insight into the disease mechanisms involved, we generated a knock-in mouse (KI) model, carrying the well documented HCM-causing CSRP3 mutation C58G. In vivo phenotyping of homozygous KI/KI mice revealed a robust cardiomyopathy phenotype with diastolic and systolic left ventricular dysfunction, which was supported by increased heart weight measurements. Transcriptome analysis by RNA-seq identified activation of pro-fibrotic signalling, induction of the fetal gene programme and activation of markers of hypertrophic signalling in these hearts. Further ex vivo analyses validated the activation of these pathways at transcript and protein level. Intriguingly, the abundance of MLP decreased in KI/KI mice by 80% and in KI/+ mice by 50%. Protein depletion was also observed in cellular studies for two further HCM-causing CSRP3 mutations (L44P and S54R/E55G). We show that MLP depletion is caused by proteasome action. Moreover, MLP C58G interacts with Bag3 and results in a proteotoxic response in the homozygous knock-in mice, as shown by induction of Bag3 and associated heat shock proteins. In conclusion, the newly generated mouse model provides insights into the underlying disease mechanisms of cardiomyopathy caused by mutations in the non-sarcomeric protein MLP. Furthermore, our cellular experiments suggest that protein depletion and proteasomal overload also play a role in other HCM-causing CSPR3 mutations that we investigated, indicating that reduced levels of functional MLP may be a common mechanism for HCM-causing CSPR3 mutations.
No takes yet. Share an insight, caveat, or question.
Ehsan et al. (2018) studied Hypertrophic Cardiomyopathy. CSRP3 mutation C58G vs. Wild-type/Heterozygous was evaluated on Cardiomyopathy phenotype and MLP protein abundance. The HCM-causing CSRP3 mutation C58G in a knock-in mouse model caused robust cardiomyopathy with left ventricular dysfunction and an 80% depletion of MLP protein due to proteasome action.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: